• 1
    Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma. Selection of post-operative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982; 49: 12211230.
  • 2
    Hudson M, Jaffe MR, Jaffe N, et al. Pediatric osteosarcoma: therapeutic strategies, results and prognostic factors derived from a 10-year experience. J Clin Oncol. 1990; 8: 19881997.
  • 3
    Winkler K, Beron G, Dellinger G, et al. Neoadjuvant chemotherapy of osteosarcoma: on histological tumor response. J Clin Oncol. 1988; 6: 329337.
  • 4
    Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering Experience. J Clin Oncol. 1992; 10: 513.
  • 5
    Link MP, Goorin AM, Miser A, et al. The effect of adjuvant chemotherapy in patients with osteosarcoma of the extremity. N Engl J Med. 1986; 314: 16001606.
  • 6
    Jaffe N. Chemotherapy in osteosarcoma: advances and controversies. In: MuggiaFM, editor. Experimental and clinical progress in cancer chemotherapy. Boston: Martinus Nijhoff Publishers, 1985: 223233.
  • 7
    Jeffree GM, Price HG, Sissons HA. The metastatic patterns of osteosarcoma. Br J Cancer. 1975; 32: 87107.
  • 8
    Benjamin RS, Chawla SP, Murray J, et al. Preoperative chemotherapy for osteosarcoma: a treatment approach facilitating limb salvage with major prognostic indications. In: JonesSF, SalmonSE, editors. Adjuvant therapy of cancer IV. Philadelphia: Grune and Stratton, 1984: 601610.
  • 9
    Picci P, Bacci G, Capanna R. Neoadjuvant chemotherapy for osteosarcoma – results of a prospective study. In RyanJR, BakerLO, editors. Recent concepts in sarcoma treatment. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1988: 291295.
  • 10
    Jaffe N, Robertson R, Takaue Y, et al. Control of primary osteosarcoma with chemotherapy. Cancer. 1985; 56: 461465.
  • 11
    Jaffe N, Prudich J, Knapp J, et al. Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate. J Clin Oncol. 1983; 1 (7): 428431.
  • 12
    Jaffe N, Knapp J, Chuang VP, et al. Osteosarcoma: intra-arterial treatment of the primary tumor with Cis-diamminedichloroplatinum II (CDP). Angiographic, pathologic and pharmacologic studies. Cancer. 1983; 51: 402407.
  • 13
    Raymond AK, Chawla SP, Carrasco CH, et al. Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol. 1987; 4: 212236.
  • 14
    Kaplan EL, Meier R. Nonparametric estimation for incomplete observation. J Am Stat Assoc. 1958; 53: 457.
  • 15
    Jaffe N, Keiffer R III, Robertson R, et al. Renal toxicity with cumulative doses of Cis-diammine-dichloroplatinum II in pediatric patients with osteosarcoma. Cancer. 1987; 59: 15771581.
  • 16
    Ruiz L, Gilden J, Jaffe N, et al. Auditory function in pediatric patients treated with multiple doses of cis-Diamminedichloroplatinum II (CDP). Cancer Res. 1989; 49: 742744.
  • 17
    Jaffe N, Smith E, Abelson HT, Frei S. Osteogenic sarcoma: alterations in the patterns of pulmonary metastases with adjuvant chemotherapy. J Clin Oncol. 1983; 1: 251254.
  • 18
    Jaffe N, Robertson R, Ayala A, et al. Comparison of intra-arterial CDP II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma. J Clin Oncol. 1985; 3: 11011104.
  • 19
    Patel S, Valhan-Raj S, Papadopolous N, et al. High-dose ifosfamide in bone and soft tissue sarcomas: dose-response and schedule dependence. J Clin Oncol. 1997; 15: 23782374.
  • 20
    Lange B, Levine AS. Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma? Cancer Treat Rep. 1982; 66: 16991704.
  • 21
    Jaffe N, van Eys J, Gehan EA. Response to “Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?” Cancer Treat Rep. 1982; 67: 743744.
  • 22
    Jaffe N. Adjuvant chemotherapy in osteogenic sarcoma. J Clin Oncol. 1984; 2: 11791181.
  • 23
    Link MP, Vietti VJ. Reply: role of adjuvant therapy in osteosarcoma. Cancer Treat Rep. 1983; 67: 744745.
  • 24
    Carter SK. Adjuvant chemotherapy in osteogenic sarcoma. The triumph that isn't? J Clin Oncol. 1984; 2: 147148.
  • 25
    Ogihara Y, Segiguchi K, Tsuruta T. Osteogenic sarcoma of the fourth thoracic vertebra. Long term survival by chemotherapy only. Cancer. 1984; 53: 26152618.
  • 26
    Sutow WW, Gehan EA, Dijmert PA, et al. Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies. Cancer Treat Rep. 1977; 62: 265270.